SSII - NASDAQ

SS Innovations International, Inc.

SSII·NASDAQ

$4.31

+7.5%

HealthcareMedical - Devices

SS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$862.57M

EPS-0.0638

P/E Ratio-67.55

Earnings Date08/10/2026

74.23M

Assets

75%

3Y+963.0%

5Y+23251.0%

10Y+25300.0%

36.01M

Total Liabilities

24%

3Y+273.0%

5Y+2934.0%

10Y+5463.0%

38.22M

Total Equity

184%

3Y-1527.0%

5Y-4498.0%

10Y-10864.0%

SS Innovations International, Inc. Funding & Solvency Profile

SSII · NASDAQ

Current Assets

Cash & Cash Equivalents3.21M

Net Receivables12.40M

Inventory17.06M

Other Current Assets16.13M

Total Current Assets49 M

Non-Current Assets

Property, Plant & Equipment11.85M

Goodwill & Intangible Assets0.00

Long-Term Investments9.03M

Other Non-Current Assets4.01M

Total Non-Current Assets25 M

Total Assets

74.23M

Financial Health Analysis

Current Ratio

1.86x

Strong liquidity. The company has adequate resources to meet short-term liabilities.

Debt-to-Equity Ratio

0.94x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

23 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

66% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

SS Innovations International, Inc. Balance Sheet

SSII • NASDAQ

SS Innovations International, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	3.2M	466.5K	7M	217.2K	405.8K	160.7K	28.5K	35.7K	452.6K	248.2K
Cash & Short-Term Investments	3.2M	466.5K	7M	217.2K	405.8K	160.7K	28.5K	35.7K	452.6K	248.2K
Net Receivables	12.4M	7.2M	1.6M	2.5M	0.0	0.0	0.0	0.0	0.0	0.0
Accounts Receivables	12.4M	4.5M	1.6M	156.9K	0.0	0.0	0.0	0.0	0.0	0.0
Other Receivables	0.0	2.7M	0.0	2.3M	0.0	0.0	0.0	0.0	0.0	0.0
Inventory	17.1M	10.2M	6.3M	904.1K	0.0	0.0	0.0	0.0	0.0	0.0
Prepaids	0.0	3.7M	0.0	424K	2.3K	2.3K	6.3K	5.8K	10.5K	465.0
Other Current Assets	16.1M	5.8M	3.4M	57.4K	0.0	0.0	0.0	0.0	0.0	0.0
Total Current Assets	48.8M	27.4M	18.4M	4.1M	408.1K	163K	34.8K	41.5K	463K	248.7K
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	11.9M	8M	3M	1.9M	20.5K	38.2K	84.6K	35.3K	3.4K	0.0
Intangible Assets	0.0	0.0	36.1K	36.1K	0.0	1.1K	13.1K	0.0	0.0	0.0
Goodwill & Intangible Assets	0.0	0.0	36.1K	36.1K	0.0	1.1K	13.1K	0.0	0.0	0.0
Long-Term Investments	9M	3.6M	2.6M	0.0	0.0	115.5K	0.0	0.0	0.0	0.0
Tax Assets	533.7K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	4M	3.3M	1.4M	934.1K	0.0	0.0	0.0	68.5K	43.5K	0.0
Total Non-Current Assets	25.4M	15M	7.1M	2.9M	20.5K	154.9K	97.8K	103.9K	46.9K	43.5K
Total Assets	74.2M	42.4M	25.5M	7M	428.6K	317.9K	132.5K	145.4K	510K	292.2K
LIABILITIES
CURRENT LIABILITIES
Total Payables	5.1M	3M	900.9K	840.5K	124.6K	131.7K	141.4K	10K	6.1K	54.8K
Accounts Payable	5.1M	2.9M	900.9K	165.5K	124.6K	131.7K	141.4K	10K	6.1K	54.8K
Other Payables	0.0	147.5K	0.0	675K	0.0	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	0.0	1.2M	2M	498.1K	17.7K	671.5K	492.8K	150K	82.5K	67.5K
Short Term Debt	579.2K	15.4M	6M	6.2M	145K	195K	457.5K	30K	0.0	480K
Capital Lease Obligations (Current)	0.0	409.5K	289K	181.9K	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	0.0	20.5K	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	3.3M	1.3M	0.0	1.8K	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	17.3M	0.0	20.5K	0.0	0.0	188.7K	104K	259.8K	320.3K	45K
Total Current Liabilities	26.2M	21.3M	9.3M	7.8M	287.3K	1.2M	1.2M	449.8K	408.9K	647.3K
NON-CURRENT LIABILITIES
Long Term Debt	2.3M	0.0	0.0	469K	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue (Non-Current)	7.1M	5.2M	0.0	42.1K	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	288.8K	74.8K	0.0	10.6K	0.0	0.0	0.0	0.0	0.0	0.0
Total Non-Current Liabilities	9.8M	7.6M	1.9M	1.9M	0.0	0.0	0.0	0.0	0.0	0.0
Capital Lease Obligations	0.0	2.8M	2.2M	1.6M	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	36M	28.9M	11.2M	9.7M	287.3K	1.2M	1.2M	449.8K	408.9K	647.3K
SHAREHOLDERS' EQUITY
Treasury Stock	0.0	0.0	0.0	0.0	-26K	0.0	0.0	0.0	0.0	0.0
Common Stock	19.4K	17.2K	67.1K	12.8K	462.3K	103.5K	2.2K	2.1K	2.1K	1.9K
Additional Paid-In Capital	95.1M	57M	49M	-12.8K	8.2M	6M	4.5M	2.2M	1.6M	128.1K
Retained Earnings	-55.8M	-43.7M	-35.3M	-3.6M	-8.5M	-7M	-5.9M	-2.5M	-1.5M	-485K
Accumulated Other Comprehensive Income/Loss	-1.1M	150.3K	704.4K	954.5K	0.0	0.0	254.6K	0.0	0.0	0.0
Other Total Stockholders' Equity	0.0	0.0	-183.6K	0.0	0.0	0.0	254.6K	81.3K	0.0	0.0
Total Stockholders' Equity	38.2M	13.5M	14.3M	-2.7M	141.3K	-869K	-1.1M	-304.3K	101.1K	-355.1K
Total Equity	38.2M	13.5M	14.3M	-2.7M	141.3K	-869K	-1.1M	-304.3K	101.1K	-355.1K
SUMMARY
Total Liabilities & Equity	74.2M	42.4M	25.5M	7M	428.6K	317.9K	132.5K	145.4K	510K	292.2K
Total Investments	9M	3.6M	2.6M	0.0	0.0	115.5K	0.0	0.0	0.0	0.0
Total Debt	2.9M	18.2M	8.2M	8.3M	145K	195K	457.5K	15K	0.0	480K
Net Debt	-289.5K	17.7M	1.2M	8M	-260.8K	34.3K	429K	-20.7K	-452.6K	231.8K
Shares Outstanding	193,621,000	193,621,000	193,621,000	193,621,000	193,621,000	193,621,000	193,621,000	193,621,000	193,621,000	193,621,000

SEC Filings

SSII - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 26, 2026	May 18, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 13, 2026	May 13, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 13, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 07, 2026	May 07, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 05, 2026	May 05, 2026	2026	View Filing
S-3 S-3 N/A	May 01, 2026	May 01, 2026		View Filing
8-K 8-K 2026 N/A	April 23, 2026	April 23, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 07, 2026	April 07, 2026	2026	View Filing
10-K/A 10-K/A 2025 FY (Amended) FY	March 31, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	March 30, 2026	March 30, 2026	2026	View Filing

Showing 1 to 10 of 155 filings

Related Guides

Blog Categories

Continue your SSII research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.